Literature DB >> 7649977

p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat.

A Gualberto1, A S Baldwin.   

Abstract

Tumor necrosis factor alpha (TNF) is a potent activator of transcription directed by the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR). We have recently reported that the p53 tumor suppressor gene product binds to a site within the Sp1 binding region of the HIV-1 LTR and contributes to the TNF induction of this promoter. In this study we show that the transcription factor Sp1 cooperates with p53 in the transcriptional activation directed by the HIV-1 LTR. The presence of Sp1 increased p53 binding to its recognition sequence in the HIV-1 LTR, and experiments in Drosophila cells show that Sp1 is necessary for full transactivation by mutant p53. Importantly, TNF induced the association between p53 and Sp1 in Jurkat T cells. These data demonstrate a synergistic role for these proteins in the mechanism of TNF induction of HIV-1 LTR-mediated transcription and suggest that Sp1 may play an important role in modulating certain functions of p53.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649977     DOI: 10.1074/jbc.270.34.19680

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

Review 2.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

3.  Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription.

Authors:  S B Kennett; A J Udvadia; J M Horowitz
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

4.  The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.

Authors:  D Mukhopadhyay; B Knebelmann; H T Cohen; S Ananth; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

5.  Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brain cells.

Authors:  C Schwartz; P Catez; O Rohr; D Lecestre; D Aunis; E Schaeffer
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Transcription factor Sp1 activates involucrin promoter activity in non-epithelial cell types.

Authors:  E B Banks; J F Crish; R L Eckert
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

7.  Differential transcriptional regulation of the human thrombin receptor gene by the Sp family of transcription factors in human endothelial cells.

Authors:  Y Wu; J Ruef; G N Rao; C Patterson; M S Runge
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

8.  P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Maria Febbraio; Daniel J Brat; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

9.  Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription.

Authors:  N Bianchi; C Rutigliano; M Passadore; M Tomassetti; L Pippo; C Mischiati; G Feriotto; R Gambari
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

10.  Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB.

Authors:  Ying Zhang; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.